中国平安更新报告“产品加服务”，打造平安新的价值增长

Investment Rating - The report maintains a "Buy" rating for China Ping An, with a target price of 88.53 CNY [2][14]. Core Insights - China Ping An's strategic positioning as a "comprehensive finance + medical care and elderly care" entity is expected to drive long-term stable profit growth through its "product + service" model, creating a new value growth engine for the company [3][14]. - The report emphasizes the importance of demographic changes, such as an aging population and the increasing significance of commercial health insurance, which will support the company's strategic focus on "comprehensive finance + medical care services" [34][38]. Financial Summary - Projected revenue growth from 913.79 billion CNY in 2023 to 1,198.34 billion CNY in 2027, with a compound annual growth rate (CAGR) of approximately 7% [6][15]. - Net profit attributable to shareholders is expected to increase from 85.67 billion CNY in 2023 to 159.49 billion CNY in 2027, reflecting a significant recovery after a 23% decline in 2023 [6][15]. - Earnings per share (EPS) is projected to rise from 4.70 CNY in 2023 to 8.81 CNY in 2027, indicating a positive trend in profitability [6][15]. Strategic Development - The report outlines four strategic development phases for China Ping An, culminating in its current focus on "comprehensive finance + medical care and elderly care" since 2021 [22][34]. - The company aims to leverage its comprehensive financial foundation, early investments in medical and elderly care, and strong technological capabilities to build a more efficient "product + service" system [14][28]. Market Positioning - China Ping An is positioned to benefit from the growing demand for health management services, driven by an aging population and increasing health awareness among consumers [38][40]. - The report highlights that the current valuation of the company is low, providing a margin of safety for investors, particularly in the context of its comprehensive financial services [14][19].